N. Anthony Coles - Aug 13, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
By: Beverly Dubs as attorney-in-fact For: N. Anthony Coles
Stock symbol
REGN
Transactions as of
Aug 13, 2021
Transactions value $
-$559,060
Form type
4
Date filed
8/16/2021, 04:04 PM
Next filing
Aug 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $691K +2K +221.73% $345.47 2.9K Aug 13, 2021 Direct F1
transaction REGN Common Stock Sale -$1.25M -2K -68.92% $625.00 902 Aug 13, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2K -15.34% $0.00 11K Aug 13, 2021 Common Stock 2K $345.47 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.